MR-guided focused ultrasound: a new generation treatment of Parkinson's disease, essential tremor and neuropathic pain.
OA: closed
Abstract
The application of high intense focused ultrasound (HIFU) is currently the subject of many experimental and clinical trials. The combination of HIFU with MRI guidance known as MR-guided focused ultrasound (MRgFUS) appears to be particularly promising to ablate tissues located deep in the brain. The method can be the beginning of interventional neurology and an important alternative to neurosurgery. Studies conducted to date show the effectiveness of the method both in chronic diseases and in emergency cases. The safety and effectiveness of this method have been observed in parkinsonian and essential tremor as well as in neuropathic pain. The procedure does not require anaesthesia. Ionizing radiation is not used and there is no risk of cumulative dose. Such advantages may result in low complication rates and medical justification for further development of MRgFUS.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (35)
- doi:10.3171/2011.10.focus11246 via crossref
- doi:10.1088/0031-9155/52/12/011 via crossref
- doi:10.1016/0360-3016(84)90379-1 via crossref
- doi:10.1046/j.1471-4159.1995.64031224.x via crossref
- doi:10.1097/00004647-199704000-00001 via crossref
- doi:10.1080/14786440908564348 via crossref
- doi:10.1085/jgp.26.2.179 via crossref
- doi:10.1126/science.122.3168.517 via crossref
- doi:10.3171/jns.1954.11.5.0471 via crossref
- doi:10.3171/jns.1959.16.1.0032 via crossref
- doi:10.1016/s0301-5629(00)00275-1 via crossref
- doi:10.1002/mds.870131303 via crossref
- doi:10.1212/wnl.0b013e318236f0fd via crossref
- doi:10.1056/nejmoa1300962 via crossref
- doi:10.1016/s1474-4422(13)70048-6 via crossref
- doi:10.1111/j.1468-1331.2006.01547.x via crossref
- doi:10.1111/j.1468-1331.2006.01548.x via crossref
- doi:10.1111/j.1468-1331.2012.03866.x via crossref
- doi:10.1111/ene.12022 via crossref
- doi:10.4065/81.1.12 via crossref
- doi:10.1111/j.1468-1331.2006.01511.x via crossref
- doi:10.4065/mcp.2009.0649 via crossref
- doi:10.1093/brain/119.2.363 via crossref
- doi:10.1093/brain/awh631 via crossref
- doi:10.3171/2011.10.focus11248 via crossref
- doi:10.1016/j.neuroimage.2004.06.046 via crossref
- doi:10.1158/0008-5472.can-12-0128 via crossref
- doi:10.1158/0008-5472.can-12-2609 via crossref
- doi:10.3171/2012.12.jns121095 via crossref
- doi:10.1227/01.neu.0000360379.95800.2f via crossref
- doi:10.5698/1535-7511-11.6.196 via crossref
- doi:10.3171/2011.10.focus11251 via crossref
- doi:10.4172/2155-9562.s1-002 via crossref
- doi:10.1097/rli.0b013e31823cc75c via crossref
- doi:10.1371/journal.pone.0042311 via crossref
Source provenance
- crossref
- last seen: 2026-05-29T01:00:05.247898+00:00
- europepmc
- last seen: 2026-07-14T06:08:30.651965+00:00
- unpaywall
- last seen: 2026-07-14T06:42:26.817772+00:00